Condensed Consolidated Statements of Net Loss (Unaudited) - USD ($)		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Revenue		$ 239,895	$ 314,568
Cost of goods sold		120,139	109,443
Gross margin		119,756	205,125
General and administrative expense		2,335,984	2,423,651
Operations expense		878,518	891,071
Sales and marketing expense		370,237	304,467
Total operating loss		(3,464,983)	(3,414,064)
Other income		42,228	42,430
Other expense		0	(989)
Gain on derivative instruments		953	1,908
Net loss		$ (3,421,802)	$ (3,370,715)
Net loss per common share - basic and diluted (in dollars per share)		$ (0.86)	$ (1.02)
Weighted average shares used in computation - basic and diluted (in shares)	[1]	3,968,099	3,291,722

[1] The following is a summary of the number of underlying shares outstanding at the end of the respective periods that have been excluded from the diluted calculations because the effect on loss per common share would have been anti-dilutive: Three Months Ended March 31, 2023 2022 Options 47,805 51,529 Restricted Stock Units 2,500 22,084 Warrants 1,812,379 1,583,063 Series B Convertible Preferred Stock 16 16